Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses
Metrics: PDF 828 views | HTML 1632 views | ?
Dong Sun Oh1,*, Heegon Kim3,4,*, Ji Eun Oh2, Hi Eun Jung1, Yun Soo Lee3,4, Ji-Ho Park3,4 and Heung Kyu Lee1,2,4
1Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology, KAIST, Daejeon, 34141, Republic of Korea
2Graduate School of Medical Science and Engineering, KAIST, Daejeon, 34141, Republic of Korea
3Department of Bio and Brain Engineering, KAIST, Daejeon, 34141, Republic of Korea
4KAIST Institute for Health Science and Technology, KAIST, Daejeon, 34141, Republic of Korea
*These authors contributed equally to this work
Ji-Ho Park, email: firstname.lastname@example.org
Heung Kyu Lee, email: email@example.com
Keywords: photodynamic therapy, immunotherapy, Treg, CD25, Chlorin e6
Received: January 06, 2017 Accepted: April 21, 2017 Published: May 07, 2017
Tumor immunotherapy aims to overcome the immunosuppressive microenvironment within tumors, and various approaches have been developed. Tumor-associated T regulatory cells (Tregs) suppress the activation and expansion of tumor antigen-specific effector T cells, thus, providing a permissive environment for tumor growth. Therefore, optimal strategies need to be established to deplete tumor-infiltrated Tregs because systemic depletion of Tregs can result in reduced anti-tumor effector cells and autoimmunity. Here, to selectively deplete Tregs in tumors, we intratumorally injected anti-CD25 antibodies conjugated to Chlorin e6 (Ce6), a photosensitizer that absorbs light to generate reactive oxygen species. Local depletion of tumor-associated Tregs with photodynamic therapy (PDT) inhibited tumor growth, which was likely due to the altered tumor immune microenvironment that was characterized by increased infiltration of CD8+ effector T cells and the expression of IFN-γ and CD107a, which is a cytolytic granule exocytosis marker in tumor tissues. Furthermore, PDT-induced intratumoral Treg depletion did not influence adaptive immune responses in a murine influenza infection model. Thus, our results show that intratumoral Treg-targeted PDT could specifically modulate tumor microenvironments by depleting Tregs and could be used as a novel cancer immunotherapy technique.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.